HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

draflazine

a nucleoside transport inhibitor; has cardioprotective effect; draflazine is the (-)-enantiomer; R 88016 is the (+)-enantiomer
Also Known As:
2-aminocarbonyl-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)-pentyl)-1-piperazineacetamide; R 75 231; R 75231; R 88 016; R 88016; R-75231; R-88016; R75231; 1-Piperazineacetamide, 2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-(5,5-bis(4-fluorophenyl)pentyl)-
Networked: 16 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Yamagata, Tsuyoshi: 1 article (01/2014)
2. Shimizu, Yukiko: 1 article (01/2014)
3. Nishiya, Yoichi: 1 article (01/2014)
4. Sekine, Susumu: 1 article (01/2014)
5. Shibata, Kenji: 1 article (01/2014)
6. Yoshida, Tetsuo: 1 article (01/2014)
7. Kamigaki, Masayo: 1 article (01/2014)
8. Sakuma, Takashi: 1 article (01/2014)
9. Fukuda, Ayumu: 1 article (01/2014)
10. Yokokawa, Sachiko: 1 article (01/2014)

Related Diseases

1. Ischemia
2. Infarction
3. Unstable Angina
4. Ischemic Contracture
5. Coronary Occlusion

Related Drugs and Biologics

1. Renin
2. Angiotensins
3. Adenosine
4. Dipyridamole (Persantine)
5. Dilazep
6. Hypoxanthine
7. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
8. Lidoflazine
9. Inosine
10. Creatine Kinase (Creatine Phosphokinase)